Johnson & JohnsonJNJNYSE
LOADING
|||
JNJ Revenue Growth (YoY Quarterly)•+6.77%
SAPRO
Growth Metrics
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +5.25% | +5.26% | +2.39% | +5.77% | +6.77% |
| Gross Profit Growth | +5.17% | +5.45% | -2.26% | +3.45% | +7.62% |
| EBITDA Growth | -25.71% | -13.20% | +174.58% | +12.08% | +72.74% |
| Operating Income Growth | -14.84% | -16.63% | +0.41% | +2.30% | +34.44% |
| Net Income Growth | -89.65% | -15.26% | +237.91% | +18.16% | +91.24% |
| EPS Growth | -89.15% | -14.88% | +238.52% | +17.44% | +89.29% |
| EPS Diluted Growth | -89.13% | -15.57% | +238.81% | +18.65% | +90.99% |
| Weighted Average Shares Growth | -4.58% | -0.01% | -0.11% | +0.51% | +0.88% |
| Weighted Average Shares Diluted Growth | -4.78% | -0.15% | -0.26% | -0.12% | +0.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +6.73% | -11.19% | +14.14% | -31.16% | +14.71% |
| Free Cash Flow Growth | -12.39% | -22.89% | +18.07% | -46.75% | +46.67% |
| Receivables Growth | +9.30% | -2.37% | +7.19% | +12.99% | +8.88% |
| Inventory Growth | +12.55% | +11.30% | +11.21% | +10.21% | +12.24% |
| Asset Growth | +7.36% | +7.49% | +12.62% | +6.79% | +8.15% |
| Book Value per Share Growth | +3.23% | +3.96% | +11.67% | +9.14% | +12.01% |
| Debt Growth | +19.48% | +24.89% | +55.36% | +22.34% | +28.09% |
| R&D Expense Growth | +43.66% | +18.26% | -8.95% | +2.21% | -25.85% |
| SG&A Expenses Growth | +3.49% | +13.48% | -0.89% | +5.62% | +12.20% |
1 / 4